With a strong background in organic, biological and medicinal chemistry, Andrew works mostly on European Patent Office prosecution and opposition cases relating to the chemistry and materials sectors
You are not stacking two versions of the same drug, you are recruiting two different branches of the bodys meal-termination machinery
*In a study of 3,250 WW Clinic patients, patients that were prescribed a GLP-1 lost on average 21% of their body weight at 12 months
It does not promise overnight transformations, but its gut-first, plant-based approach appeals to users seeking sustainability
These are not direct head-to-head trial results, so the usual caution still applies
In late-stage trials, people taking orforglipron lost an average of about 12% of their body weight over roughly 72 weeks , and head-to-head studies suggest it may outperform standard oral semaglutide tablets (Rybelsus) in both weight loss and blood sugar control